150 related articles for article (PubMed ID: 32652700)
21. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression.
Luan FL; Steffick DE; Gadegbeku C; Norman SP; Wolfe R; Ojo AO
Am J Transplant; 2009 Jan; 9(1):160-8. PubMed ID: 18976304
[TBL] [Abstract][Full Text] [Related]
22. Steroid or calcineurin inhibitor-sparing immunosuppressive protocols.
Grinyó JM; Cruzado JM
Contrib Nephrol; 2005; 146():30-42. PubMed ID: 15567918
[TBL] [Abstract][Full Text] [Related]
23. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
[TBL] [Abstract][Full Text] [Related]
24. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
25. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
Chakrabarti P; Wong HY; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Hakala TR; Fung JJ; Simmons RL; Starzl TE; Shapiro R
Transplantation; 2000 Sep; 70(5):760-4. PubMed ID: 11003353
[TBL] [Abstract][Full Text] [Related]
26. Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.
Dharnidharka VR; Schnitzler MA; Chen J; Brennan DC; Axelrod D; Segev DL; Schechtman KB; Zheng J; Lentine KL
Transpl Int; 2016 Nov; 29(11):1226-1236. PubMed ID: 27564782
[TBL] [Abstract][Full Text] [Related]
27. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome.
Opelz G
Transplantation; 1994 Aug; 58(4):443-6. PubMed ID: 8073513
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant mortality and graft failure after induction immunosuppression among Black heart transplant recipients in the United States.
Salia S; Mostofsky E; Gupta S; Lehman L; Barrera FJ; Liou L; Motiwala SR; Mittleman MA
Am J Transplant; 2022 Nov; 22(11):2586-2597. PubMed ID: 35758522
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data.
Lentine KL; Lam NN; Caliskan Y; Alhamad T; Xiao H; Schnitzler MA; Chang SH; Axelrod D; Segev DL; McAdams-DeMarco M; Kasiske BL; Hess GP; Brennan DC
Clin Transplant; 2020 Dec; 34(12):e14118. PubMed ID: 33048372
[TBL] [Abstract][Full Text] [Related]
30. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
[TBL] [Abstract][Full Text] [Related]
31. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.
Cillo U; Bechstein WO; Berlakovich G; Dutkowski P; Lehner F; Nadalin S; Saliba F; Schlitt HJ; Pratschke J
Transplant Rev (Orlando); 2018 Jul; 32(3):142-150. PubMed ID: 29709248
[TBL] [Abstract][Full Text] [Related]
32. Impact of Induction Immunosuppression Strategies in Simultaneous Liver/Kidney Transplantation.
Kamal L; Yu JW; Reichman TW; Kang L; Bandyopadhyay D; Kumar D; King A; Gautam U; Bhati C; Yakubu I; Lacy K; Levy M; Gupta G
Transplantation; 2020 Feb; 104(2):395-403. PubMed ID: 31022149
[TBL] [Abstract][Full Text] [Related]
33. Steroid withdrawal after renal transplantation: a retrospective cohort study.
Haller MC; Kammer M; Kainz A; Baer HJ; Heinze G; Oberbauer R
BMC Med; 2017 Jan; 15(1):8. PubMed ID: 28077142
[TBL] [Abstract][Full Text] [Related]
34. Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.
Lopez-Soler RI; Chan R; Martinolich J; Park L; Ata A; Chandolias N; Conti DJ
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27888534
[TBL] [Abstract][Full Text] [Related]
35. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
[TBL] [Abstract][Full Text] [Related]
37. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
39. Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes.
Werbel WA; Bae S; Yu S; Al Ammary F; Segev DL; Durand CM
Am J Transplant; 2021 Feb; 21(2):717-726. PubMed ID: 32681603
[TBL] [Abstract][Full Text] [Related]
40. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.
Alkadi MM; Kim J; Aull MJ; Schwartz JE; Lee JR; Watkins A; Lee JB; Dadhania DM; Seshan SV; Serur D; Kapur S; Suthanthiran M; Hartono C; Muthukumar T
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28921709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
